These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7113316)

  • 21. [Immunosuppressive therapy in patients with HBeAg-positive chronic active hepatitis B?].
    Maier KP; Lepiorz H; Berthold H; Gerok W
    Leber Magen Darm; 1982 Aug; 12(4):150-3. PubMed ID: 7132529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Morphologic findings in liver tissue in chronic active hepatitis B after seroconversion from HBeAg to anti-HBe].
    Chlumská A; Stránský J; Taimr P; Baumruk L; Nevaril M
    Vnitr Lek; 1995 Jul; 41(7):445-8. PubMed ID: 7571477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural history of hepatitis B.
    Marcellin P; Castelnau C; Martinot-Peignoux M; Boyer N
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):63-75. PubMed ID: 15756147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: their relations to HBeAg status and the activity of liver disease.
    Bozkaya H; Bozdayi M; Türkyilmaz R; Sarioglu M; Cetinkaya H; Cinar K; Köse K; Yurdaydin C; Uzunalimoglu O
    Hepatogastroenterology; 2000; 47(36):1675-9. PubMed ID: 11149030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
    Bujanda L; García Bengoechea M; Cilla G; Gil I; yArenas JI
    Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical importance of assessment of HBsAg/IgM complexes in chronic hepatitis B.
    Stránský J; Vodák M; Zichová M
    Acta Virol; 1993; 37(2-3):170-4. PubMed ID: 8105661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Special problems of virus hepatitis B in pediatrics (author's transl)].
    Feist D
    Leber Magen Darm; 1980 Aug; 10(4):187-92. PubMed ID: 7192791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The prevalence and clinical significance of precore and core promoter mutations in Korean patients with chronic hepatitis B virus infection].
    Kim HJ; Yoo BC
    Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):149-56. PubMed ID: 12499800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Risk of hepatitis B virus transmission by highly viremic chronic carriers in schools].
    Repp R; Seuchter C; Breitbach B; Lampert F; Gerlich WH
    Zentralbl Hyg Umweltmed; 1993 Feb; 194(1-2):126-33. PubMed ID: 8333890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver function and hepatitis markers in carriers of hepatitis B virus in New Zealand.
    Hopkirk N; Moyes CD; Lucas CR
    N Z Med J; 2000 Apr; 113(1107):114-6. PubMed ID: 10834277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis E virus as an etiology of acute exacerbation of previously unrecognized asymptomatic patients with hepatitis B virus-related chronic liver disease.
    Kumar M; Sharma BC; Sarin SK
    J Gastroenterol Hepatol; 2008 Jun; 23(6):883-7. PubMed ID: 18070014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrafamilial transmission of hepatitis B in Tuzla region of Bosnia and Herzegovina.
    Salkic NN; Zildzic M; Muminhodzic K; Pavlovic-Calic N; Zerem E; Ahmetagic S; Mott-Divkovic S; Alibegovic E
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):113-8. PubMed ID: 17272995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular immune responses in patients with dual infection of hepatitis B and C viruses: dominant role of hepatitis C virus.
    Tsai SL; Liaw YF; Yeh CT; Chu CM; Kuo GC
    Hepatology; 1995 Apr; 21(4):908-12. PubMed ID: 7535736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion.
    Chu CM; Liaw YF
    J Viral Hepat; 2007 Mar; 14(3):147-52. PubMed ID: 17305879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of HBeAg on vertical transmission of hepatitis B virus (author's transl)].
    Yu HL
    Zhonghua Yi Xue Za Zhi; 1981 Jul; 61(7):399-401. PubMed ID: 6805897
    [No Abstract]   [Full Text] [Related]  

  • 37. Fulminant hepatitis B in successive female sexual partners of two anti-HBe-positive males.
    Fagan EA; Smith PM; Davison F; Williams R
    Lancet; 1986 Sep; 2(8506):538-40. PubMed ID: 2875281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of immunopotentiator on six patients with HBeAg positive chronic hepatitis (author's transl)].
    Kosaka Y; Tameda Y; Nishimura A; Fujimoto M
    Nihon Shokakibyo Gakkai Zasshi; 1981 Aug; 78(8):1675. PubMed ID: 7321268
    [No Abstract]   [Full Text] [Related]  

  • 39. [Circulation of the hepatitis B virus in an institution for the severely handicapped. II. Employment of personnel having antibodies against the virus B surface antigen in the assistance to HBeAg-positive children].
    Biadaioli R; Losco D; De Martino M; Veneruso G; Vierucci A
    Ann Sclavo; 1983; 24(3):213-20. PubMed ID: 6615030
    [No Abstract]   [Full Text] [Related]  

  • 40. [Membranous glomerulonephritis associated with chronic hepatitis B virus infection. Pathogenic role of HBeAg].
    Yebra Bango M; Marazuela Azpíroz M; Menéndez Caro JL; Manzano Espinosa L
    Med Clin (Barc); 1987 Jun; 89(2):85-6. PubMed ID: 3613752
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.